Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a large and very diverse group of neoplasms. Clinical presentation of NETs depends on the site of the primary tumor and whether the tumor is functioning (i.e., secreting peptides or neuroamines that produce symptoms). The diagnosis of GEP-N...

Descripción completa

Detalles Bibliográficos
Autores principales: Kos-Kudła, Beata, Ćwikła, Jarosław, Ruchała, Marek, Hubalewska-Dydejczyk, Alicja, Jarzab, Barbara, Krajewska, Jolanta, Kamiński, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611500/
https://www.ncbi.nlm.nih.gov/pubmed/28947880
http://dx.doi.org/10.5114/wo.2017.68619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611500/
https://www.ncbi.nlm.nih.gov/pubmed/28947880
http://dx.doi.org/10.5114/wo.2017.68619

Ejemplares similares